Please sign in to follow a disease.
Massive global study aims to speed up TB diagnosis at local clinics
NCT ID NCT05845112
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study tested several tuberculosis (TB) diagnostic tools in over 14,000 people across seven countries. The goal was to find tests that are accurate enough to use in local clinics, without needing special lab equipment. Researchers looked at a simple blood test for C-reactive protein (CRP) and other combinations to see which works best for different groups, including people with HIV and children.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- C-Reactive Protein (CRP) point-of-care test
- What this could lead to
- If successful, this could lead to simpler, more accurate TB tests that work in local clinics, helping more people get diagnosed and treated sooner.
- What could go wrong
- This is a diagnostic accuracy study, not a treatment trial. Even if tests perform well, they still need to be rolled out and used effectively in real-world settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
14,747 people
The number who actually took part.
- Started
-
Feb 2025
- Finished
-
Mar 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Individuals suspected of having TB.
- Ages
-
1 year and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
1. Inclusion criteria for Individuals attending stationary health facilities: health-seeking persons presenting at participating study site health facilities who are: * Age 15 years and above * PLHIV irrespective of their CD4 count and antiretroviral therapy (ART) status * At risk of pulmonary and/or extra-pulmonary TB OR * People with a positive WHO-recommended four-symptom screen (W4SS) or parenchymal abnormalities on chest radiography * Written informed consent and agreement to follow-up after enrolment (e.g. not planning to relocate) * A parent or guardian present at the time of enrolment to provide signed informed consent and assent signed for those aged 15 years to age of majority • Exclusion * Current anti-TB treatment (counting from the third dose) * Any anti-TB treatment within 60 days prior to enrolment * Any TB preventive therapy within 6 months prior to enrolment 2. Inclusion criteria for refugees and IDPs * health-seeking persons resident in official refugee camps who have cross international borders from other countries; OR * internally displaced individuals (IDPs), defined as persons forced or obliged to flee or to leave their homes to avoid the effects of armed conflict, situations of generalized violence, violations of human rights or natural or human-made disasters, and who have not crossed an internationally recognized state border. * IDPs can be recruited from refugee camps or among individuals sharing accommodation with local residents. * At the time they are presenting at participating study site health facilities. * Clinical criteria will be the same as described for individuals attending health facilities • Exclusion * Same as described for individuals attending health facilities and * Individuals who intend to leave the local area in the short term and have no means of contact 3. Inclusion criteria for nomadic populations * Participants will be selected using active case finding through community screening camps targeting the nomadic population (nomadic are defined as a member of a group of people who have no fixed home and move according to the seasons from place to place in search of food, water, and grazing land and are usually herders with traditional hierarchies. * The dates and locations of screening days will coincide with community market days, after consultation with nomadic community leaders * Clinical criteria will be the same as described for individuals attending health facilities • Exclusion * Same as described for individuals attending health facilities and Individuals who intend to leave the local area in the short term and have no means of contact 4. Inclusion criteria for informal settlements, urban vulnerable groups and the rural poor * Participants will be selected using active case finding through community screening activities targeting urban vulnerable groups and the rural poor. * Screening will be conducted on dates and in locations agreed with community leaders, depending on the setting. * Clinical criteria will be the same as described for individuals attending health facilities. • Exclusion * Same as described for individuals attending health facilities and Individuals who intend to leave the local area in the short term and have no means of contact. 5. Inclusion criteria for children health-seeking children presenting at participating study site health facilities who: * Are between 12 months and 15 years of age. * Have presumptive TB based on at least one criterion among the following: * Persistent cough for more than 2 weeks * Persistent fever for more than 2 weeks * Recent failure to thrive (documented clear deviation from a previous growth trajectory in the last 3 months or Z score weight/age \< 2) * Failure of broad-spectrum antibiotics for treatment of pneumonia to improve symptoms and signs * Suggestive CXR features OR * History of contact with a person with TB and any of the symptoms listed above with a shorter duration (\< 2 weeks), if the child is HIV infected or presents with Severe Acute Malnutrition * A parent or guardian present at the time of enrolment to provide signed informed consent and assent signed by children \> 7 years old. * \> 5 days of anti-TB treatment in the last 3 months or individuals receiving TB preventive therapy * Children \<12 months old
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Diagnosis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHPR
Bamenda, Cameroon
-
Friends for International TB Relief
Hà Nội, Vietnam
-
Fundação de Apoio à Pesquisa e Extensão de Sergipe
Sergipe, Brazil
-
Icddr,B
Dhaka, Bangladesh
-
Janna Health Foundation
Adamawa, Nigeria
-
KEMRI
Kisumu, Kenya
-
Malawi-Liverpool-Wellcome Clinical
Blantyre, Malawi
-
Zankli Research Centre, Bingham University
Abuja, Nigeria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Once-Daily HIV pill with food match Twice-Daily dosing during TB treatment?
- Can simple sputum and urine tests catch tuberculosis earlier?
- Can MRI replace surgery for staging bladder cancer?
- Can a common virus be turned into a TB vaccine? scientists test VIR-1778
- Fish oil meets TB drugs: can Omega-3 help clear infection faster?
- Can starting TB treatment immediately save lives in HIV sepsis?